Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Tyra Biosciences
TYRA
$1.9B
| $885K | ﹤0.01% |
37,625
+25,106
| +201% | +$527K |
|
3352
Astronics
ATRO
$3.43B
| $883K | ﹤0.01% |
54,376
+41,676
| +328% | +$708K |
|
3353
Patria Investments
PAX
$1.75B
| $882K | ﹤0.01% |
78,977
+59,900
| +314% | +$711K |
|
3354
Anavex Life Sciences
AVXL
$255M
| $881K | ﹤0.01% |
155,179
+64,101
| +70% | +$370K |
|
|
STER
3355
DELISTED
Sterling Check Corp. Common Stock
STER
| $880K | ﹤0.01% |
52,639
+40,346
| +328% | +$639K |
|
|
BFS
3356
Saul Centers
BFS
$836M
| $878K | ﹤0.01% |
20,932
+15,424
| +280% | +$607K |
|
3357
Oil States International
OIS
$489M
| $876K | ﹤0.01% |
190,480
+90,252
| +90% | +$432K |
|
3358
CALL
Marathon Digital Holdings
MARA
$4.32B
| $876K | ﹤0.01% |
54,000
-330,000
| -86% | -$5.98M |
|
3359
Titan International
TWI
$466M
| $875K | ﹤0.01% |
107,669
+72,612
| +207% | +$577K |
|
3360
PUT
Solventum
SOLV
$14.8B
| $875K | ﹤0.01% |
+12,550
| New | +$755K |
|
3361
i3 Verticals
IIIV
$412M
| $874K | ﹤0.01% |
41,036
+21,709
| +112% | +$487K |
|
|
INVX
3362
Innovex International
INVX
$1.96B
| $874K | ﹤0.01% |
59,523
+45,876
| +336% | +$736K |
|
|
MLNK
3363
DELISTED
MeridianLink
MLNK
| $872K | ﹤0.01% |
42,399
+32,808
| +342% | +$741K |
|
3364
NETGEAR
NTGR
$648M
| $870K | ﹤0.01% |
43,385
+4,125
| +11% | +$68.2K |
|
|
ALX
3365
Alexander's
ALX
$1.3B
| $869K | ﹤0.01% |
3,584
+2,821
| +370% | +$652K |
|
3366
MetroCity Bankshares
MCBS
$1.01B
| $868K | ﹤0.01% |
28,341
+21,979
| +345% | +$638K |
|
|
TEF
3367
DELISTED
Telefonica
TEF
| $866K | ﹤0.01% |
178,271
+30,738
| +21% | +$140K |
|
3368
Grindr
GRND
$3.08B
| $866K | ﹤0.01% |
72,580
+37,477
| +107% | +$444K |
|
3369
Luxfer Holdings
LXFR
$456M
| $865K | ﹤0.01% |
66,809
+26,112
| +64% | +$304K |
|
3370
PUT
Wynn Resorts
WYNN
$10.3B
| $863K | ﹤0.01% |
+9,000
| New | +$724K |
|
3371
Southern First Bancshares
SFST
$591M
| $862K | ﹤0.01% |
25,303
+8,111
| +47% | +$261K |
|
3372
CALL
Dave & Buster's
PLAY
$377M
| $861K | ﹤0.01% |
25,300
-198,400
| -89% | -$6.76M |
|
3373
Allient
ALNT
$1.49B
| $861K | ﹤0.01% |
45,362
+17,216
| +61% | +$395K |
|
3374
Mission Produce
AVO
$1.11B
| $860K | ﹤0.01% |
67,092
+50,680
| +309% | +$562K |
|
3375
Evolv Technologies
EVLV
$995M
| $857K | ﹤0.01% |
211,551
+164,775
| +352% | +$575K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.